Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Jeff Januska, PharmD
Director of Pharmacy
CenCal Health
Goleta, CA
Authored Items
Medical Care Costs and Hospitalization in Patients with Bipolar Disorder Treated with Atypical Antipsychotics
Joette Gdovin Bergeson, PhD, MPA
,
Jeff Januska, PharmD
,
Iftekhar Kalsekar, PhD
,
Yonghua Jing, PhD
,
Min You, MS
,
Robert A. Forbes, PhD
,
Tony Hebden, PhD
September/October 2012 Vol 5, No 6
in
Practice Management
A Comparison of Drug Formularies and the Potential for Cost-Savings
Andrea L. Kjos, PharmD, PhD
,
Jeff Januska, PharmD
,
Jon C. Schommer, PhD
,
Yingli Yuan, PhD
September/October 2010, Vol 3, No 5
in
Practice Management
Alzheimer's Disease: A Healthcare Burden of Epidemic Proportion
T. S. Dharmarajan, MD, FACP, AGSF
,
Jeff Januska, PharmD
,
Srinivas G. Gunturu, MD
January 2009, Vol 2, No 1
in
Original Research
Obesity: Effective Treatment Requires Change in Payers' Perspective
Rhonda Greenapple, MSPH
,
Jeff Januska, PharmD
,
Jackie Ngai, MS
March/April 2010, Vol 3, No 2
in
Practice Management
Health Plan Retention and Pharmacy Costs of Newly Diagnosed Patients with Chronic Kidney Disease in a Managed Care Population
Maureen Kubacki, PharmD, MBA
,
Jeff Januska, PharmD
,
Chureen Carter, PharmD, MS
,
Alan D. L. Herrera, PharmD
,
Jim Wang, PhD
,
Janice M.S. Lopez, PharmD, MPH
,
Catherine T. Piech, MBA
November/December 2009, Vol 2, No 7
in
Practice Management
Last modified: September 6, 2013